Genoray Co. Ltd (122310) - Total Liabilities

Latest as of September 2025: ₩48.41 Billion KRW ≈ $32.81 Million USD

Based on the latest financial reports, Genoray Co. Ltd (122310) has total liabilities worth ₩48.41 Billion KRW (≈ $32.81 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Genoray Co. Ltd cash conversion from operations to assess how effectively this company generates cash.

Genoray Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Genoray Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Genoray Co. Ltd to evaluate the company's liquid asset resilience ratio.

Genoray Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Genoray Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Kafein Yazilim IS:KFEIN	Turkey	TL393.08 Million
Ascent Solar Technologies, Inc. Common Stock NASDAQ:ASTI	USA	$2.99 Million
Jinli Group Holdings Ltd TW:8429	Taiwan	NT$671.49 Million
Covalon Technologies Ltd. V:COV	Canada	CA$5.40 Million
Corem Property Group AB (publ) ST:CORE-A	Sweden	Skr36.64 Billion
Mentice AB ST:MNTC	Sweden	Skr152.53 Million
Caprice Resources Ltd AU:CRS	Australia	AU$375.09K
Ihuman Inc NYSE:IH	USA	$384.80 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Genoray Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 122310 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.94	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.62	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.39	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genoray Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genoray Co. Ltd (2015–2024)

The table below shows the annual total liabilities of Genoray Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩37.55 Billion ≈ $25.45 Million	+30.68%
2023-12-31	₩28.74 Billion ≈ $19.47 Million	+57.59%
2022-12-31	₩18.23 Billion ≈ $12.36 Million	-11.29%
2021-12-31	₩20.56 Billion ≈ $13.93 Million	+6.96%
2020-12-31	₩19.22 Billion ≈ $13.02 Million	+1.51%
2019-12-31	₩18.93 Billion ≈ $12.83 Million	+40.58%
2018-12-31	₩13.47 Billion ≈ $9.13 Million	+0.24%
2017-12-31	₩13.44 Billion ≈ $9.11 Million	-27.72%
2016-12-31	₩18.59 Billion ≈ $12.60 Million	+8.17%
2015-12-31	₩17.18 Billion ≈ $11.65 Million	--

About Genoray Co. Ltd

KQ:122310 Korea Diagnostics & Research

Market Cap

$38.45 Million

₩56.74 Billion KRW

Market Cap Rank

#22822 Global

#1576 in Korea

Share Price

₩4620.00

Change (1 day)

-2.63%

52-Week Range

₩3810.00 - ₩5910.00

All Time High

₩11740.92